Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials

[1] Alicic RZ(2017)Diabetic kidney disease: challenges, progress, and possibilities Clin J Am Soc Nephrol 12 2032-45

[2] Rooney MT(2014)Global estimates of diabetes prevalence for 2013 and projections for 2035 Diabetes Res Clin Pract 103 137-49

[3] Tuttle KR(2019)The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases J Transl Med 17 264-11

[4] Guariguata L(2017)Total flavones of Abelmoschus manihot improve diabetic nephropathy by inhibiting the iRhom2/TACE signalling pathway activity in rats Pharm Biol 56 1-9

[5] Whiting DR(2018)Amelioration of diabetic nephropathy in db/db mice treated with tibetan medicine formula Siwei Jianghuang Decoction Powder extract Sci Rep 8 16707-64

[6] Hambleton I(2016)Tripterygium glycosides for treating late-onset rheumatoid arthritis: A systematic review and Meta-analysis Altern Ther Health Med 22 32-30

[7] Wang G(2019)Effect of Tripterygium glycosides tablets in treating rheumatoid arthritis: a systematic review and Meta-analysis Zhongguo Zhong Yao Za Zhi 44 3358-4

[8] Ouyang J(2015)Comparison of Tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study BMC Nephrol 16 200-7

[9] Li S(2019)Traditional Chinese medicine versus regular therapy in Henoch-Schönlein purpura nephritis in children: study protocol for a randomized controlled trial Trials 20 538-9

[10] Liu S(2017)Multi-glycoside of Tripterygium wilfordii Hook. F. attenuates glomerulosclerosis in a rat model of diabetic nephropathy by exerting anti-microinflammatory effects without affecting hyperglycemia Int J Mol Med 40 721-51

[1] Alicic RZ(2017)Diabetic kidney disease: challenges, progress, and possibilities Clin J Am Soc Nephrol 12 2032-45

[2] Rooney MT(2014)Global estimates of diabetes prevalence for 2013 and projections for 2035 Diabetes Res Clin Pract 103 137-49

[3] Tuttle KR(2019)The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases J Transl Med 17 264-11

[4] Guariguata L(2017)Total flavones of Abelmoschus manihot improve diabetic nephropathy by inhibiting the iRhom2/TACE signalling pathway activity in rats Pharm Biol 56 1-9

[5] Whiting DR(2018)Amelioration of diabetic nephropathy in db/db mice treated with tibetan medicine formula Siwei Jianghuang Decoction Powder extract Sci Rep 8 16707-64

[6] Hambleton I(2016)Tripterygium glycosides for treating late-onset rheumatoid arthritis: A systematic review and Meta-analysis Altern Ther Health Med 22 32-30

[7] Wang G(2019)Effect of Tripterygium glycosides tablets in treating rheumatoid arthritis: a systematic review and Meta-analysis Zhongguo Zhong Yao Za Zhi 44 3358-4

[8] Ouyang J(2015)Comparison of Tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study BMC Nephrol 16 200-7

[9] Li S(2019)Traditional Chinese medicine versus regular therapy in Henoch-Schönlein purpura nephritis in children: study protocol for a randomized controlled trial Trials 20 538-9

[10] Liu S(2017)Multi-glycoside of Tripterygium wilfordii Hook. F. attenuates glomerulosclerosis in a rat model of diabetic nephropathy by exerting anti-microinflammatory effects without affecting hyperglycemia Int J Mol Med 40 721-51